New pill aims to shrink HER2 tumors and brain metastases
Disease control
Recruiting now
This early-stage trial tests a new drug called IAM1363 in adults with advanced cancers that have HER2 alterations, including breast, lung, and stomach cancers that have spread to the brain. The goal is to find a safe dose and see if the drug can shrink tumors. About 383 participa…
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated May 07, 2026 18:40 UTC